Treatment of extrafoveal lesions
Intravitreal Ranibizumab appears to be more effective than thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularisation secondary to agerelated macular degeneration, according to the results of a retrospective study. In a study involving 24 eyes with the extrafoveal neovascularisations, the mean best corrected visual acuity was significantly better in eyes receiving the anti-VEGF agent than in those undergoing the laser treatment (logMAR 0.16 vs 0.92, p = 0.02) at a mean follow-up of 26 weeks. Moreover, the recurrence rate in the laser group was 84.6 per cent, compared to only 18.2 per cent in the ranibizumab group (p < 0.001).
(Ladas et al, Ophthalmologica 2012; DOI: 10.1159/000337347.)
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Picture This: Photo Contest Winners
ESCRS 2025 Refractive and Cataract Photo Contest winners.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.